Oppenheimer USA | OPY - Le Bénéfice D'Exploitation

Prix De L'Action
114.00
Variation Quotidienne
1.36 1.21%
Mensuellement
36.36%
Annuel
107.51%
Q2 Prévisions
110.16




Le Bénéfice D'Exploitation Changement Date
Bank Of America USD 10.4B 782M 2026-03
Barclays GBP 1.93B 359M 2025-12
BGC Partners USD 31.24M 74.88M 2025-09
Canaccord Genuity CAD -6.87M 25.79M 2025-09
Citigroup USD 7.68B 2.42B 2026-03
Deutsche Bank EUR 2.17B 3.97B 2025-12
Evercore Partners USD 316.87M 97.15M 2025-12
Goldman Sachs USD 6.53B 579M 2026-03
JPMorgan USD 20.7B 3.16B 2026-03
Matsui Securities JPY 6.75B 1.14B 2025-12
Moelis & Company USD 128.01M 79.69M 2025-12
Morgan Stanley USD 7.19B 1.39B 2026-03
Oppenheimer USA USD 126.11M 90.74M 2025-12
Piper Sandler Companies USD 188.86M 2.03B 2025-12
Prospect Capital USD 102.65M 113.68M 2025-12
Raymond James Financial USD 738M 599M 2025-12
Reinet Investments EUR 375M 336M 2025-12
Scully Royalty CAD 1.34M 3.11M 2025-06
Stifel Financial USD 307.91M 21.86M 2025-12
Transnational Corp Of Nigeria NGN 63.68B 17.95B 2025-12
UMB Financial USD 270.31M 1.85M 2025-12
Wells Fargo USD 5.98B 1.27B 2026-03
XP BRL 1.61B 2.75B 2025-12